Pulmonary Perspectives®
Pulmonary Perspectives®
Inhaled corticosteroids for COVID-19
Over time, OCS therapy has gained acceptance as a treatment for moderate-to-severe COVID-19.
Pulmonary Perspectives®
Transitioning from fellow to attending
Pulmonary Perspectives®
Lung transplantation for patients with severe COVID-19
Pulmonary Perspectives®
Advancing bronchoscopy: Reaching the unreachable
Pulmonary Perspectives®
Are we there yet? Lung cancer screening – current landscape
Pulmonary Perspectives®
2020 Focused Updates to the Asthma Management Guidelines
A new report has provided a much-needed update in the evaluation and management of asthma.
Pulmonary Perspectives®
Bronchiolitis: Rare diseases, diagnostic challenges, and few proven therapies
Bronchiolitis is a well-recognized complication in a significant number of patients who have undergone lung or stem cell transplantation.
Pulmonary Perspectives®
Options grow for interstitial lung disease other than idiopathic pulmonary fibrosis
As more clinical trials are published, clinicians are now facing a different dilemma.
Pulmonary Perspectives®
Bronchoscopy and tracheostomy in the COVID-19 era
Aerosol-generating procedures (AGP), such as bronchoscopy and tracheostomy, are high-risk for viral transmission.
Pulmonary Perspectives®
Telehealth in the COVID-19 era: The New York experience
Prior to the COVID-19 pandemic, only 15% of medical practices offered telehealth services and 8% of Americans joined in remote visits annually.